News & Updates

Which factor predicts successful interval extension in eyes with nAMD switched to brolucizumab?
Which factor predicts successful interval extension in eyes with nAMD switched to brolucizumab?
31 Jul 2023

In patients with neovascular age-related macular degeneration (nAMD) who switched to brolucizumab treatment, those with shorter treatment interval before switching are more likely to have successful injection interval extension, as shown in a study.

Which factor predicts successful interval extension in eyes with nAMD switched to brolucizumab?
31 Jul 2023